Edwards Lifesciences’ CEO Revises Existing Stock Trading Plan

Edwards Lifesciences Corporation, a global leader in products and technologies to treat advanced cardiovascular disease, announced that its chairman and chief executive officer, Michael A. Mussallem, has revised his existing pre-arranged stock trading plan under Rule 10b5-1 of the Securities and Exchange Act of 1934.
News Blaze